Connection

Jacques Izopet to Antiviral Agents

Back to Details
This is a "connection" page, showing publications Jacques Izopet has written about Antiviral Agents.
Jacques Izopet
Connection Strength
0.298
Antiviral Agents
  1. Ribavirin for chronic hepatitis E virus infection. N Engl J Med. 2014 06 19; 370(25):2447-8.
    View in: PubMed
    Score: 0.054
  2. Pegylated interferon-alpha for treating chronic hepatitis E virus infection after liver transplantation. Clin Infect Dis. 2010 Mar 01; 50(5):e30-3.
    View in: PubMed
    Score: 0.040
  3. Hydroxychloroquine in Coronavirus Disease 2019 Patients: What Still Needs to Be Known About the Kinetics. Clin Infect Dis. 2020 12 31; 71(11):2962-2964.
    View in: PubMed
    Score: 0.021
  4. Plasma Hepatitis E Virus Kinetics in Solid Organ Transplant Patients Receiving Ribavirin. Viruses. 2019 07 09; 11(7).
    View in: PubMed
    Score: 0.019
  5. Should 12- or 24-week post-ribavirin follow-up be considered to define sustained virological response in transplant patients treated for chronic hepatitis E virus infection? Transpl Infect Dis. 2019 06; 21(3):e13065.
    View in: PubMed
    Score: 0.019
  6. Failure to respond to ribavirin despite elevated intra-erythrocyte zinc level in transplant-patients with chronic hepatitis E virus infection. Transpl Infect Dis. 2019 04; 21(2):e13050.
    View in: PubMed
    Score: 0.019
  7. Executive summary of the 2018 KDIGO Hepatitis C in CKD Guideline: welcoming advances in evaluation and management. Kidney Int. 2018 10; 94(4):663-673.
    View in: PubMed
    Score: 0.018
  8. Should Persistent Hepatitis E Virus Replication in Transplant Patients Be Tolerated? Transplantation. 2018 02; 102(2):e84-e85.
    View in: PubMed
    Score: 0.017
  9. Baseline and post-treatment hepatitis C NS5A resistance in relapsed patients from a multicentric real-life cohort. Antivir Ther. 2018; 23(4):307-314.
    View in: PubMed
    Score: 0.017
  10. Retreatment with direct-acting antivirals of genotypes 1-3-4 hepatitis C patients who failed an anti-NS5A regimen in real world. J Hepatol. 2018 03; 68(3):595-597.
    View in: PubMed
    Score: 0.017
  11. Chronic hepatitis E virus infection in a cirrhotic patient: A case report. Medicine (Baltimore). 2017 Sep; 96(39):e7915.
    View in: PubMed
    Score: 0.017
  12. Treatment of hepatitis C virus infection after kidney transplantation. Contrib Nephrol. 2012; 176:87-96.
    View in: PubMed
    Score: 0.011
  13. [Cytomegalovirus effects in solid organ transplantation and the role of antiviral prophylaxis]. Nephrol Ther. 2010 Nov; 6(6):505-12.
    View in: PubMed
    Score: 0.010
  14. Monitoring hepatitis E virus fecal shedding to optimize ribavirin treatment duration in chronically infected transplant patients. J Hepatol. 2019 01; 70(1):206-209.
    View in: PubMed
    Score: 0.005
  15. Hepatitis E virus-associated cryoglobulinemia in solid-organ-transplant recipients. Liver Int. 2018 12; 38(12):2178-2189.
    View in: PubMed
    Score: 0.004
  16. Hepatitis E virus infection. Nat Rev Dis Primers. 2017 Nov 16; 3:17086.
    View in: PubMed
    Score: 0.004
  17. Transfusion-acquired hepatitis E infection misdiagnosed as severe critical illness polyneuromyopathy in a heart transplant patient. Transpl Infect Dis. 2017 Dec; 19(6).
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.